Evidence map›Paper›PMID 41620396›Full record

ArticleCell death & disease2026

Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS).

Emily Carroll, Jakub Scaber, Iris-Stefania Pasniceanu, Ruxandra Dafinca, David Gordon, Ana Candalija, Kevin Talbot

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emily CarrollNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Jakub ScaberNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Iris-Stefania PasniceanuNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Ruxandra DafincaNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
David GordonNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Ana CandalijaNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Kevin TalbotNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. kevin.talbot@ndcn.ox.ac.uk.ORCID http://orcid.org/0000-0001-5490-1697

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TDP-43 dysfunction is thought to be central to ALS pathogenesis. Studying mutations in the gene which encodes TDP-43, TARDBP, provides a valuable opportunity to gain insight into how TDP-43 dysfunction alters cellular homoeostasis. Our group has previously developed a TDP-43

Indexed as

Amyotrophic Lateral SclerosisAxonal TransportDNA-Binding ProteinsGlycolysisMotor NeuronsMouse Embryonic Stem CellsAnimalsCell SurvivalDisease Models, AnimalHumansMiceMutationDNA-Binding ProteinsTARDBP protein, humanTardbp protein, mouse

Identifiers

PMID41620396
PMCPMC12877184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.